HTGMQ

0.00010.00%
PC

Patrick C. Roche

Senior Vice President of Research & Development

Dr. Patrick C. Roche, also known as Pat, Ph.D., serves as Senior Vice President of Research and Development at HTG Molecular Diagnostics, Inc. and served as its Senior Vice President of Medical and Scientific Affairs since April 2014. Dr. Roche served as Senior Vice President for IVD Assay Development at HTG Molecular Diagnostics, Inc. since April 09, 2014. Dr. Roche joined HTG from Ventana, a medical diagnostics company and member of the Roche Group and global headquarters of RTD, where he worked for 12 years and held a number of positions of increasing responsibility, including Vice President, Head Biomarker Strategy, Translational Diagnostics, from August 2009 to April 2014 and Vice President, Assay Development and Clinical Studies, from March 2007 to July 2009. In these roles, Dr. Roche was responsible for interfacing with pharmaceutical partners in their development of targeted cancer therapeutics and facilitating the transition of biomarkers into companion diagnostics and for leading reagent product development and launching over 30 in vitro diagnostic products, including the FDA-approved c-kit and HER2 tests. Prior to working at Ventana, Dr. Roche was at the Mayo Clinic Rochester, a medical research group, where he served as Director of the Immunohistochemistry Laboratory and as Associate Professor of Laboratory Medicine and Pathology. Dr. Roche has co-authored more than 125 peer-reviewed publications and is an inventor on a number of patent filings and two issued U.S. patents. Dr. Roche received a B.S. in Biological Sciences from the University of Southern California and a Ph.D. in Experimental Pathology from the University of Southern California, School of Medicine.

Positions